ciprofloxacin has been researched along with Crohn Disease in 59 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Crohn Disease: A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate, in a prospective, open-label study, the influence of antibiotics and azathioprine on the clinical outcome of perianal fistulas in patients with Crohn's disease." | 9.10 | Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease. ( Dejaco, C; Harrer, M; Miehsler, W; Reinisch, W; Vogelsang, H; Waldhoer, T, 2003) |
| "Remission and response of perianal fistulas were defined as closure of all fistulas and closure of at least 50% of fistulas that were draining at baseline, respectively." | 6.74 | Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study. ( Bernstein, CN; Bitton, A; Cockeram, A; Feagan, BG; Mahadevan, U; Sandborn, WJ; Thia, KT; Wong, C, 2009) |
| "Ciprofloxacin is effective in perianal Crohn's disease but after treatment discontinuation symptoms reoccur." | 6.71 | Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebo-controlled study. ( Drapers, JA; Felt-Bersma, RJ; Hansen, BE; Kuipers, EJ; van der Woude, CJ; van Tilburg, AJ; West, RL, 2004) |
| "In this study we aimed to determine the microorganisms found in perianal fistulas in Crohn's disease and whether treatment with ciprofloxacin affects these microorganisms." | 5.11 | Perianal fistulas in Crohn's disease are predominantly colonized by skin flora: implications for antibiotic treatment? ( Boelens, HA; Endtz, HP; Hansen, BE; Kuipers, EJ; Kusters, JG; Ouwedijk, M; Van der Woude, CJ; West, RL, 2005) |
| "To evaluate, in a prospective, open-label study, the influence of antibiotics and azathioprine on the clinical outcome of perianal fistulas in patients with Crohn's disease." | 5.10 | Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease. ( Dejaco, C; Harrer, M; Miehsler, W; Reinisch, W; Vogelsang, H; Waldhoer, T, 2003) |
| "Microorganisms, their ciprofloxacin resistance, and clinical outcomes were retrospectively analyzed in 78 CD patients with intra-abdominal abscesses, who underwent percutaneous drainage between March 1991, and November 2011." | 3.80 | Ciprofloxacin usage and bacterial resistance patterns in Crohn's disease patients with abscesses. ( Byeon, JS; Duk Ye, B; Jung, KW; Kim, JH; Kim, KJ; Lee, SO; Myung, SJ; Park, SK; Sik Yu, C; Yang, DH; Yang, SK, 2014) |
| "Fifty-two patients (median age 36 yr) with draining perianal fistulas were treated with ciprofloxacin (N = 49) or metronidazole (N = 3) for a median duration of 7 wk." | 3.74 | NOD2/CARD15 gene variants are linked to failure of antibiotic treatment in perianal fistulating Crohn's disease. ( Angelberger, S; Dejaco, C; Lichtenberger, C; Miehsler, W; Reinisch, W; Schaeffeler, E; Schwab, M; Teml, A; Vogelsang, H; Waldhoer, T; Wehkamp, J, 2008) |
| "coli are present in Crohn's disease, but their role in pathogenesis is uncertain." | 3.01 | Randomized Trial of Ciprofloxacin Doxycycline and Hydroxychloroquine Versus Budesonide in Active Crohn's Disease. ( Butterworth, J; Culshaw, K; Dallal, H; Flanagan, PK; Hart, A; Horgan, GW; Iqbal, T; Mansfield, J; Martin, K; Parkes, M; Probert, C; Rhodes, JM; Subramanian, S, 2021) |
| "Remission and response of perianal fistulas were defined as closure of all fistulas and closure of at least 50% of fistulas that were draining at baseline, respectively." | 2.74 | Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study. ( Bernstein, CN; Bitton, A; Cockeram, A; Feagan, BG; Mahadevan, U; Sandborn, WJ; Thia, KT; Wong, C, 2009) |
| "Relapse was defined as an increase in CDAI of >100 points." | 2.71 | Lactobacillus GG in inducing and maintaining remission of Crohn's disease. ( Herfarth, HH; Rath, HC; Sartor, RB; Schultz, M; Timmer, A; Vanderhoof, JA, 2004) |
| "Ciprofloxacin is effective in perianal Crohn's disease but after treatment discontinuation symptoms reoccur." | 2.71 | Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebo-controlled study. ( Drapers, JA; Felt-Bersma, RJ; Hansen, BE; Kuipers, EJ; van der Woude, CJ; van Tilburg, AJ; West, RL, 2004) |
| "In patients with active Crohn's disease of the ileum, the addition of ciprofloxacin and metronidazole to budesonide is an ineffective intervention, but this antibiotic combination may improve outcome when there is involvement of the colon." | 2.70 | Combined budesonide and antibiotic therapy for active Crohn's disease: a randomized controlled trial. ( Bitton, A; Cohen, A; Croitoru, K; Drouin, E; Feagan, BG; Greenberg, GR; Leddin, DJ; Mikolainis, S; Seidman, E; Steinhart, AH; Vandervoort, M; Wong, CJ, 2002) |
| "The etiology of Crohn's disease remains uncertain, and to date no therapy is curative." | 2.42 | Antibiotics should be used as first-line therapy for Crohn's disease. ( Greenberg, GR, 2004) |
| " Moreover, long-term use of glucocorticosteroids is associated with serious and sometimes irreversible side effects." | 2.42 | An historical overview of the treatment of Crohn's disease: why do we need biological therapies? ( Rutgeerts, PJ, 2004) |
| "In general, patients with Crohn's disease are not usually offered IPAA, because recurrence of disease, fistulas, abscesses, and strictures may lead to a higher incidence of pouch failure." | 2.41 | Complications after ileal pouch-anal anastomosis. ( Lichtenstein, GR; Stein, RB, 2000) |
| "Many of the perianal lesions of Crohn's disease respond to short-term metronidazole, and the medium-term (3-6 months) use of broad-spectrum antibiotics, most recently ciprofloxacin, has shown promising results." | 2.39 | On the use of antibiotics in Crohn's disease. ( Van Kruiningen, HJ, 1995) |
| "Stool samples and rectal and perianal fistula swabs were collected." | 1.72 | A Microbial Signature for Paediatric Perianal Crohn's Disease. ( Albenberg, L; Baldassano, RN; Bittinger, K; Breton, J; Devas, N; Hwang, R; Kachelries, K; Mattei, P; Rowley, S; Tanes, C; Tu, V; Wu, GD, 2022) |
| "The elective treatment for acute pouchitis is antibiotics." | 1.56 | Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 2: Treatment. ( Barreiro-de Acosta, M; Beltrán, B; Chaparro, M; Espín, E; Ferrer Bradley, I; Gisbert, JP; Guarner, F; Gutiérrez, A; Marín-Jimenez, I; Nos, P; Rodríguez-Lago, I, 2020) |
| "Ciprofloxacin was selected because of its extensive coverage for intestinal flora, relatively favorable side-effect profile and preliminary data suggesting its efficacy in the treatment of active Crohn's Disease." | 1.43 | Methacrylate micro/nano particles prepared by spray drying: a preliminary in vitro/in vivo study. ( Marín Boscá, MT; Muñoz Ortega, B; Sallam, MA, 2016) |
| "We report three patients with terminal ileitis and positive fecal cultures with Yersinia pseudotuberculosis." | 1.40 | Difficulties in diagnosing terminal ileitis due to Yersinia pseudotuberculosis. ( Frénay, IH; Fruth, A; Kuijper, EJ; Notermans, DW; Oostvogel, PM; Wunderink, HF, 2014) |
| "Fistulas were treated with antibiotics in 59." | 1.38 | Genital fistulas in female Crohn's disease patients.: clinical characteristics and response to therapy. ( Bermejo, F; de la Poza, G; Gisbert, JP; López-Sanroman, A; Marín-Jimenez, I; Muriel, A; Opio, V; Taxonera, C, 2012) |
| "CD-associated perianal fistulas are mainly complex." | 1.38 | Endoscopic ultrasound for perianal Crohn's disease: disease and fistula characteristics, and impact on therapy. ( Assulin, Y; Beer-Gabel, M; Chowers, Y; Lahat, A, 2012) |
| "Nevertheless, patients with perianal fistulas and CARD15 mutations showed worse response to antibiotics." | 1.37 | CARD15 mutations and perianal fistulating Crohn's disease: correlation and predictive value of antibiotic response. ( Andrade, P; Donato, MM; Ferreira, M; Freire, P; Portela, F; Sofia, C, 2011) |
| "Ampicillin was not effective against intracellular E." | 1.35 | Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics. ( Campbell, BJ; Edwards, SW; Hart, CA; Martin, HM; Rhodes, JM; Roberts, CL; Subramanian, S, 2008) |
| "paratuberculosis; isolates from Crohn's disease patients tended to be more susceptible than were bovine-origin isolates." | 1.35 | Thiopurine drugs azathioprine and 6-mercaptopurine inhibit Mycobacterium paratuberculosis growth in vitro. ( Collins, MT; Shin, SJ, 2008) |
| "Colonoscopy diagnosed IBD, a Crohn's disease-like pattern." | 1.35 | De-novo [corrected] post renal transplantation inflammatory bowel disease. ( Al-Otaibi, T; Balaha, MA; El-Sayed, A; Elsisi, A; Halim, MA; Nair, P; Nampoory, MR; Said, T, 2008) |
| "Perianal fistulizing Crohn's disease (PFCD) treatment is based on fistula drainage, antibiotics, immunosuppressant (IS) drugs, and infliximab." | 1.35 | Predicting factors of fistula healing and clinical remission after infliximab-based combined therapy for perianal fistulizing Crohn's disease. ( Koning, E; Lerebours, E; Michot, F; Savoye, G; Savoye-Collet, C; Tougeron, D, 2009) |
| "A pediatric patient with Crohn's disease and colitis with cryptitis developed a prolonged Q-T interval within 48 hours of treatment with ciprofloxacin." | 1.35 | Ciprofloxacin-induced Q-T interval prolongation. ( Knorr, JP; Moshfeghi, M; Sokoloski, MC, 2008) |
| "Recto-urethral fistulas due to Crohn's disease are very uncommon." | 1.35 | [Urethral fistula due to Crohn's disease: case report of successful conservative management]. ( Borovicka, J; Engeler, DS; Hetzer, FH; Meyer, D; Schmid, HP; Schwab, C, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (11.86) | 18.2507 |
| 2000's | 32 (54.24) | 29.6817 |
| 2010's | 13 (22.03) | 24.3611 |
| 2020's | 7 (11.86) | 2.80 |
| Authors | Studies |
|---|---|
| Subramanian, S | 2 |
| Roberts, CL | 1 |
| Hart, CA | 1 |
| Martin, HM | 1 |
| Edwards, SW | 1 |
| Rhodes, JM | 2 |
| Campbell, BJ | 1 |
| Shin, SJ | 1 |
| Collins, MT | 1 |
| Breton, J | 1 |
| Tanes, C | 1 |
| Tu, V | 1 |
| Albenberg, L | 1 |
| Rowley, S | 1 |
| Devas, N | 1 |
| Hwang, R | 1 |
| Kachelries, K | 1 |
| Wu, GD | 1 |
| Baldassano, RN | 1 |
| Bittinger, K | 1 |
| Mattei, P | 1 |
| Barreiro-de Acosta, M | 1 |
| Marín-Jimenez, I | 2 |
| Rodríguez-Lago, I | 1 |
| Guarner, F | 1 |
| Espín, E | 1 |
| Ferrer Bradley, I | 1 |
| Gutiérrez, A | 1 |
| Beltrán, B | 1 |
| Chaparro, M | 1 |
| Gisbert, JP | 2 |
| Nos, P | 1 |
| Limketkai, BN | 1 |
| Akobeng, AK | 1 |
| Gordon, M | 1 |
| Adepoju, AA | 1 |
| Flanagan, PK | 1 |
| Horgan, GW | 1 |
| Martin, K | 1 |
| Mansfield, J | 1 |
| Parkes, M | 1 |
| Hart, A | 1 |
| Dallal, H | 1 |
| Iqbal, T | 1 |
| Butterworth, J | 1 |
| Culshaw, K | 1 |
| Probert, C | 1 |
| Begbey, A | 1 |
| Guppy, JH | 1 |
| Mohan, C | 1 |
| Webster, S | 1 |
| Effinger, A | 1 |
| McAllister, M | 1 |
| Tomaszewska, I | 1 |
| O'Driscoll, CM | 1 |
| Taylor, M | 1 |
| Gomersall, S | 1 |
| Heaton, J | 1 |
| Smith, KL | 1 |
| Sarcevica, I | 1 |
| Young, SL | 1 |
| Fotaki, N | 1 |
| Kayal, M | 1 |
| Bhagya Rao, B | 1 |
| Bhattacharya, A | 1 |
| Ungaro, R | 1 |
| Cazals-Hatem, D | 1 |
| Kale-Pradhan, PB | 1 |
| Zhao, JJ | 1 |
| Palmer, JR | 1 |
| Wilhelm, SM | 1 |
| Herfarth, HH | 2 |
| Katz, JA | 1 |
| Hanauer, SB | 1 |
| Sandborn, WJ | 2 |
| Loftus, EV | 1 |
| Sands, BE | 2 |
| Galanko, JA | 1 |
| Walkup, D | 1 |
| Isaacs, KL | 1 |
| Martin, CF | 1 |
| Sandler, RS | 1 |
| Sartor, RB | 2 |
| Dewint, P | 1 |
| Hansen, BE | 3 |
| Verhey, E | 1 |
| Oldenburg, B | 1 |
| Hommes, DW | 1 |
| Pierik, M | 1 |
| Ponsioen, CI | 1 |
| van Dullemen, HM | 1 |
| Russel, M | 1 |
| van Bodegraven, AA | 1 |
| van der Woude, CJ | 3 |
| Gupta, NK | 1 |
| Masia, R | 1 |
| Wunderink, HF | 1 |
| Oostvogel, PM | 1 |
| Frénay, IH | 1 |
| Notermans, DW | 1 |
| Fruth, A | 1 |
| Kuijper, EJ | 1 |
| Park, SK | 1 |
| Kim, KJ | 1 |
| Lee, SO | 1 |
| Yang, DH | 1 |
| Jung, KW | 1 |
| Duk Ye, B | 1 |
| Byeon, JS | 1 |
| Myung, SJ | 1 |
| Yang, SK | 1 |
| Kim, JH | 1 |
| Sik Yu, C | 1 |
| Su, JW | 1 |
| Ma, JJ | 1 |
| Zhang, HJ | 1 |
| Muñoz Ortega, B | 1 |
| Sallam, MA | 1 |
| Marín Boscá, MT | 1 |
| Massa, AF | 1 |
| Campos, MA | 1 |
| Baptista, A | 1 |
| Costa, C | 1 |
| Lima, O | 1 |
| Osório Ferreira, E | 1 |
| Halim, MA | 1 |
| Al-Otaibi, T | 1 |
| Elsisi, A | 1 |
| El-Sayed, A | 1 |
| Nair, P | 1 |
| Said, T | 1 |
| Balaha, MA | 1 |
| Nampoory, MR | 1 |
| Thia, KT | 1 |
| Mahadevan, U | 1 |
| Feagan, BG | 3 |
| Wong, C | 1 |
| Cockeram, A | 1 |
| Bitton, A | 2 |
| Bernstein, CN | 1 |
| Tougeron, D | 1 |
| Savoye, G | 1 |
| Savoye-Collet, C | 1 |
| Koning, E | 1 |
| Michot, F | 1 |
| Lerebours, E | 1 |
| Freire, P | 1 |
| Portela, F | 1 |
| Donato, MM | 1 |
| Ferreira, M | 1 |
| Andrade, P | 1 |
| Sofia, C | 1 |
| de la Poza, G | 1 |
| López-Sanroman, A | 1 |
| Taxonera, C | 1 |
| Bermejo, F | 1 |
| Opio, V | 1 |
| Muriel, A | 1 |
| Lahat, A | 1 |
| Assulin, Y | 1 |
| Beer-Gabel, M | 1 |
| Chowers, Y | 1 |
| Bamias, G | 1 |
| Marini, M | 1 |
| Moskaluk, CA | 1 |
| Odashima, M | 1 |
| Ross, WG | 1 |
| Rivera-Nieves, J | 1 |
| Cominelli, F | 1 |
| Bataille, L | 1 |
| Rahier, J | 1 |
| Geubel, A | 1 |
| Tomás, ME | 1 |
| Pérez Carreras, M | 1 |
| Morillasa, JD | 1 |
| Castellano, G | 1 |
| Solís, JA | 1 |
| Ishikawa, T | 1 |
| Okamura, S | 1 |
| Oshimoto, H | 1 |
| Kobayashi, R | 1 |
| Mori, M | 1 |
| Castiglione, F | 1 |
| Rispo, A | 1 |
| Di Girolamo, E | 1 |
| Cozzolino, A | 1 |
| Manguso, F | 1 |
| Grassia, R | 1 |
| Mazzacca, G | 1 |
| Dejaco, C | 2 |
| Harrer, M | 1 |
| Waldhoer, T | 2 |
| Miehsler, W | 2 |
| Vogelsang, H | 2 |
| Reinisch, W | 2 |
| Schultz, M | 1 |
| Timmer, A | 1 |
| Vanderhoof, JA | 1 |
| Rath, HC | 1 |
| Greenberg, GR | 3 |
| Wild, GE | 1 |
| Mow, WS | 1 |
| Landers, CJ | 1 |
| Steinhart, AH | 2 |
| Croitoru, K | 2 |
| Seidman, E | 2 |
| Targan, SR | 1 |
| Rutgeerts, PJ | 1 |
| West, RL | 2 |
| Felt-Bersma, RJ | 1 |
| van Tilburg, AJ | 1 |
| Drapers, JA | 1 |
| Kuipers, EJ | 2 |
| Gionchetti, P | 1 |
| Rizzello, F | 1 |
| Morselli, C | 1 |
| Romagnoli, R | 1 |
| Campieri, M | 1 |
| Endtz, HP | 1 |
| Ouwedijk, M | 1 |
| Boelens, HA | 1 |
| Kusters, JG | 1 |
| Dignass, AU | 1 |
| Elliott, PR | 1 |
| Moore, GT | 1 |
| Bell, SJ | 1 |
| Connell, WR | 1 |
| Bressler, B | 1 |
| Atienza, P | 1 |
| Myers, AL | 1 |
| Colombo, J | 1 |
| Jackson, MA | 1 |
| Harrison, CJ | 1 |
| Roberts, CR | 1 |
| Knorr, JP | 1 |
| Moshfeghi, M | 1 |
| Sokoloski, MC | 1 |
| Angelberger, S | 1 |
| Wehkamp, J | 1 |
| Lichtenberger, C | 1 |
| Schaeffeler, E | 1 |
| Schwab, M | 1 |
| Teml, A | 1 |
| Schwab, C | 1 |
| Meyer, D | 1 |
| Hetzer, FH | 1 |
| Borovicka, J | 1 |
| Schmid, HP | 1 |
| Engeler, DS | 1 |
| Van Kruiningen, HJ | 1 |
| Prantera, C | 3 |
| Kohn, A | 2 |
| Zannoni, F | 2 |
| Spimpolo, N | 1 |
| Bonfa, M | 1 |
| Peppercorn, MA | 1 |
| Scribano, ML | 2 |
| Berto, E | 2 |
| Andreoli, A | 1 |
| Luzi, C | 1 |
| Shetty, AK | 1 |
| Udall, J | 1 |
| Schmidt-Sommerfeld, E | 1 |
| Falasco, G | 1 |
| Colombel, JF | 1 |
| Lémann, M | 1 |
| Cassagnou, M | 1 |
| Bouhnik, Y | 1 |
| Duclos, B | 1 |
| Dupas, JL | 1 |
| Notteghem, B | 1 |
| Mary, JY | 1 |
| Stein, RB | 1 |
| Lichtenstein, GR | 1 |
| Marteau, P | 1 |
| Seksik, P | 1 |
| Arnold, GL | 1 |
| Beaves, MR | 1 |
| Pryjdun, VO | 1 |
| Mook, WJ | 1 |
| Wong, CJ | 1 |
| Vandervoort, M | 1 |
| Mikolainis, S | 1 |
| Leddin, DJ | 1 |
| Drouin, E | 1 |
| Cohen, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Randomised Study to Compare Combination Antibiotic Therapy (Ciprofloxacin, Doxycycline and Hydroxychloroquine) With Standard Therapy (Budesonide) in the Treatment of Active Crohn's Disease[NCT01783106] | Phase 2 | 59 participants (Actual) | Interventional | 2014-02-01 | Completed | ||
| Adalimumab for the Treatment of Perianal Fistulas in Crohn's Disease More Effective Alone or Combined to Ciprofloxacin[NCT00736983] | Phase 3 | 76 participants (Actual) | Interventional | 2008-09-30 | Completed | ||
| A Prospective Longitudinal Study on the Effect of Tight Control Management on Perianal Crohn's Disease[NCT03861689] | 40 participants (Anticipated) | Interventional | 2019-07-01 | Enrolling by invitation | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
12 reviews available for ciprofloxacin and Crohn Disease
| Article | Year |
|---|---|
Probiotics for induction of remission in Crohn's disease.
Topics: Adult; Anti-Bacterial Agents; Bifidobacterium longum; Ciprofloxacin; Crohn Disease; Gastrointestinal | 2020 |
[Histoseminar on inflammatory bowel diseases (IBD): Case n
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Biopsy; Ciprofloxacin; Colon; Crohn Disease; Diagnosis, | 2017 |
The role of antimicrobials in Crohn's disease.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Crohn Disease; Humans; Metronidazole; R | 2013 |
Use of antibiotics in patients with Crohn's disease: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Crohn Disease; Humans; Randomized Controlled Trials as Topic | 2015 |
Antibiotics should be used as first-line therapy for Crohn's disease.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Crohn Disease; Humans; Imipenem; Metronidazole; Time | 2004 |
The role of antibiotics in the management of Crohn's disease.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clinical Trials as Topic; Crohn Disease; Drug Therapy, Combina | 2004 |
An historical overview of the treatment of Crohn's disease: why do we need biological therapies?
Topics: Anti-Infective Agents; Biological Therapy; Ciprofloxacin; Crohn Disease; Glucocorticoids; Humans; Im | 2004 |
Management of inflammatory bowel disease: does rifaximin offer any promise?
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Clinical Trials as Topic; Colitis, Ulcerative; Crohn | 2005 |
Review article: Medical therapy for fistulizing Crohn's disease.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Ciprofloxacin; Crohn Diseas | 2006 |
[Refractory perineal fistulas in Crohn's disease].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Ciprofloxacin; Crohn Diseas | 2007 |
On the use of antibiotics in Crohn's disease.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Crohn Disease; Dogs; Humans; Metronidazole | 1995 |
Complications after ileal pouch-anal anastomosis.
Topics: Anastomosis, Surgical; Ciprofloxacin; Colitis, Ulcerative; Crohn Disease; Humans; Male; Metronidazol | 2000 |
16 trials available for ciprofloxacin and Crohn Disease
| Article | Year |
|---|---|
Randomized Trial of Ciprofloxacin Doxycycline and Hydroxychloroquine Versus Budesonide in Active Crohn's Disease.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Budesonide; Ciprofloxacin; Crohn Disease; Cross-Ove | 2021 |
Ciprofloxacin for the prevention of postoperative recurrence in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study.
Topics: Adolescent; Adult; Anastomosis, Surgical; Anti-Infective Agents; Ciprofloxacin; Crohn Disease; Doubl | 2013 |
Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI).
Topics: Adalimumab; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Mo | 2014 |
Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Crohn Disease; Double-Blind Method; Female; Humans; Mal | 2009 |
Metronidazole plus ciprofloxacin therapy for active Crohn's disease.
Topics: Adult; Anti-Infective Agents; Blood Sedimentation; C-Reactive Protein; Ciprofloxacin; Crohn Disease; | 2003 |
Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn's disease.
Topics: Adult; Aged; Anti-Infective Agents; Bacterial Infections; Breath Tests; Ciprofloxacin; Colonic Disea | 2003 |
Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anus Diseases; Azathioprine; | 2003 |
Lactobacillus GG in inducing and maintaining remission of Crohn's disease.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Crohn Disease; Double-Blind Method; Drug Therapy, Combination; | 2004 |
High-level serum antibodies to bacterial antigens are associated with antibiotic-induced clinical remission in Crohn's disease: a pilot study.
Topics: Anti-Infective Agents; Antibodies, Antineutrophil Cytoplasmic; Antigens, Bacterial; Budesonide; Cipr | 2004 |
Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebo-controlled study.
Topics: Adolescent; Adult; Anti-Infective Agents; Antibodies, Monoclonal; Ciprofloxacin; Crohn Disease; Doub | 2004 |
Perianal fistulas in Crohn's disease are predominantly colonized by skin flora: implications for antibiotic treatment?
Topics: Adult; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Corynebacterium Infections; Crohn | 2005 |
Metronidazole plus ciprofloxacin in the treatment of active, refractory Crohn's disease: results of an open study.
Topics: Adult; Aged; Ciprofloxacin; Crohn Disease; Drug Therapy, Combination; Female; Humans; Male; Metronid | 1994 |
An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Ciprofloxacin; Crohn Disea | 1996 |
A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Ciprofloxacin; Crohn Disease; | 1999 |
Preliminary study of ciprofloxacin in active Crohn's disease.
Topics: Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Crohn Disease; Female; Humans; Male; Middle Aged; | 2002 |
Combined budesonide and antibiotic therapy for active Crohn's disease: a randomized controlled trial.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Budesonide; Ciprofloxacin; Colon; Crohn Disease; | 2002 |
31 other studies available for ciprofloxacin and Crohn Disease
| Article | Year |
|---|---|
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cells, Cultured; Colon; Crohn Disease; Culture Media; Esc | 2008 |
Thiopurine drugs azathioprine and 6-mercaptopurine inhibit Mycobacterium paratuberculosis growth in vitro.
Topics: Animals; Azathioprine; Bacteriological Techniques; Cattle; Cattle Diseases; Colony Count, Microbial; | 2008 |
A Microbial Signature for Paediatric Perianal Crohn's Disease.
Topics: Ciprofloxacin; Crohn Disease; Ecosystem; Humans; Rectal Fistula; Treatment Outcome | 2022 |
Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 2: Treatment.
Topics: Acute Disease; Advisory Committees; Algorithms; Anti-Bacterial Agents; Biological Products; Budesoni | 2020 |
Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Cl | 2020 |
Investigating the Impact of Crohn's Disease on the Bioaccessibility of a Lipid-Based Formulation with an In Vitro Dynamic Gastrointestinal Model.
Topics: Administration, Oral; Animals; Bile Acids and Salts; Ciprofloxacin; Crohn Disease; Excipients; Fasti | 2021 |
Clinical Challenge: From Ulcerative Colitis to Crohn's Disease-Like Pouch Inflammation.
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Ciprofloxacin; Colitis, Ulcerative; Crohn Di | 2021 |
Cord colitis syndrome: a cause of granulomatous inflammation in the upper and lower gastrointestinal tract.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Colitis; Cord Blood Stem Cell Transplantation; Crohn Di | 2013 |
Difficulties in diagnosing terminal ileitis due to Yersinia pseudotuberculosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteriological Techniques; Ciprofloxacin; Crohn Disease; | 2014 |
Ciprofloxacin usage and bacterial resistance patterns in Crohn's disease patients with abscesses.
Topics: Abdominal Abscess; Adolescent; Adult; Anti-Bacterial Agents; Ciprofloxacin; Crohn Disease; Drainage; | 2014 |
Methacrylate micro/nano particles prepared by spray drying: a preliminary in vitro/in vivo study.
Topics: Acrylic Resins; Administration, Oral; Ciprofloxacin; Crohn Disease; Desiccation; Drug Liberation; Ex | 2016 |
Paediatric anogenital Crohn's disease 11 years after Lichen planus - same background for two different entities?
Topics: Anal Canal; Azathioprine; Child; Ciprofloxacin; Crohn Disease; Drug Therapy, Combination; Female; Ge | 2016 |
De-novo [corrected] post renal transplantation inflammatory bowel disease.
Topics: Adult; Aminosalicylic Acids; Ciprofloxacin; Crohn Disease; Humans; Immunosuppressive Agents; Inflamm | 2008 |
Predicting factors of fistula healing and clinical remission after infliximab-based combined therapy for perianal fistulizing Crohn's disease.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Ciprof | 2009 |
CARD15 mutations and perianal fistulating Crohn's disease: correlation and predictive value of antibiotic response.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Crohn Disease; Drug Therapy, Combination; Female; Genet | 2011 |
Genital fistulas in female Crohn's disease patients.: clinical characteristics and response to therapy.
Topics: Adalimumab; Adolescent; Adult; Age Factors; Anti-Infective Agents; Anti-Inflammatory Agents; Antibod | 2012 |
Endoscopic ultrasound for perianal Crohn's disease: disease and fistula characteristics, and impact on therapy.
Topics: Abscess; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Infective Agents; Anti-Inflammatory | 2012 |
Down-regulation of intestinal lymphocyte activation and Th1 cytokine production by antibiotic therapy in a murine model of Crohn's disease.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cells, Cultured; Ciprofloxacin; Crohn Disease; | 2002 |
Delayed and prolonged cholestatic hepatitis with ductopenia after long-term ciprofloxacin therapy for Crohn's disease.
Topics: Anti-Infective Agents; Bile Ducts; Chemical and Drug Induced Liver Injury; Cholestasis; Chronic Dise | 2002 |
[Rupture of the Achilles' tendon secondary to levofloxacin].
Topics: Achilles Tendon; Adult; Ceftriaxone; Ciprofloxacin; Crohn Disease; Drug Therapy, Combination; Humans | 2003 |
[Management of perianal fistulizing Crohn's disease: a conservative approach].
Topics: Anti-Infective Agents; Ciprofloxacin; Combined Modality Therapy; Crohn Disease; Fecal Incontinence; | 2005 |
Severe recurrent Crohn's disease of the ileocolonic anastomosis disappearing completely with antibacterial therapy.
Topics: Adult; Anastomosis, Surgical; Anti-Bacterial Agents; Ciprofloxacin; Colon; Crohn Disease; Humans; Il | 2005 |
Tuberculous colitis mimicking Crohn disease.
Topics: Abdominal Pain; Adolescent; Anastomosis, Surgical; Anti-Infective Agents; Antitubercular Agents; App | 2007 |
Ciprofloxacin-induced Q-T interval prolongation.
Topics: Abscess; Acetamides; Adolescent; Anti-Infective Agents; Aztreonam; Bradycardia; Ciprofloxacin; Crohn | 2008 |
NOD2/CARD15 gene variants are linked to failure of antibiotic treatment in perianal fistulating Crohn's disease.
Topics: Adult; Alleles; Anti-Infective Agents; beta-Defensins; Ciprofloxacin; Crohn Disease; Female; Genetic | 2008 |
[Urethral fistula due to Crohn's disease: case report of successful conservative management].
Topics: Azathioprine; Ciprofloxacin; Crohn Disease; Cystoscopy; Cystostomy; Diagnosis, Differential; Drug Th | 2008 |
Is there a role for antibiotics as primary therapy in Crohn's ileitis?
Topics: Adult; Aged; Ciprofloxacin; Crohn Disease; Female; Humans; Ileitis; Male; Middle Aged | 1993 |
Highly destructive perianal Crohn's disease.
Topics: Adolescent; Anti-Infective Agents; Anti-Inflammatory Agents; Anus Diseases; Ciprofloxacin; Colostomy | 1998 |
Use of antibiotics in the treatment of active Crohn's disease: experience with metronidazole and ciprofloxacin.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Cro | 1998 |
Case problem: medical nutrition therapy for a patient with Crohn's disease.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Body Weight; Ciprofloxacin; Crohn Disease; Diarrhea | 2000 |
[Role of prebiotics and probiotics in therapeutic management of cryptogenetic inflammatory bowel disease].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Ciprofloxacin | 2001 |